Key Points
The union government has reduced GST on three cancer drugs from 12% to 5%, following an earlier exemption from basic customs duty...
The GST council, headed by Finance Minister Nirmala Sitharaman, slashed the Goods and Services Tax on three cancer drugs from 12% to 5%...
These anti-cancer medicines are immune and targeted therapies such as trastuzumab deruxtecan, osimertinib, and durvalumab, sold by British-Swedish pharmaceutical and biotechnology company AstraZeneca...
The expert also suggested lowering the cost of nivolumab, another type of targeted therapy drug for cancers of the lining of the urinary tract.. . Anti-cancer drugs pose a significant financial burden on Indian patients..
A global study from 2022 found that even though many high-priority cancer drugs identified by Indian oncologists, primarily generic chemotherapy agents, are comparatively affordable but remained out of reach for patients due to financial constraints.. . ) ..
